Pfizer
Antonia Papadaki has a robust background in risk management, compliance, and auditing, currently serving as a Risk Management & Compliance Senior Analyst at Pfizer since May 2022. Prior to this role, Antonia worked at PwC Greece as a Senior Audit Associate and Audit Associate from January 2021 to May 2022, and at Mazars as an Assistant Auditor from January 2017 to January 2021. Antonia gained foundational experience as an Internal Audit Intern at the Black Sea Trade & Development Bank in 2016 and completed internships at the Thessaloniki Chamber of Commerce and Industry in 2014. Additionally, Antonia served as a Bloomberg Institute Ambassador in 2013. Academic qualifications include an MSc in Applied Accounting and Auditing from the University of Macedonia and an undergraduate degree in Business Administration from the same institution, complemented by an ACCA qualification.
This person is not in any teams
This person is not in any offices
Pfizer
619 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.